Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease - Concepedia

Concepedia

Publication | Closed Access

Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease

260

Citations

26

References

2013

Year

Kenneth Cusi, Zhihui Chang, Steve Harrison, Romina Lomonaco, Fernando Bril, Beverly Orsak, Carolina Ortiz‐Lopez, Joan Hecht, Ariel E. Feldstein, Amy Webb,

Journal of Hepatology

ObesityMetabolic SyndromeInflammationMetabolic Associated SteatohepatitisFibrosisHepatologyNonalcoholic Fatty Liver DiseaseLiver PhysiologyPathologyChronic InflammationLimited ValueLiver DiseaseHepatology FibrosisPlasma Cytokeratin-18Fatty Liver DiseaseMedicineHealth Sciences

References

	Year	Citations

Page 1

Page 1